Skip to content
Trial Eligibility
Menu

Lung Cancer Clinical Trials near San Antonio, TX

84 studies for Lung Cancer are recruiting at 98 sites within 50 miles of San Antonio, Texas, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lung Cancer trials in the US or all trials near San Antonio.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lung Cancer studies enrolling near San Antonio

Showing the 50 nearest of 84 studies.
  1. Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

    NCT07226999

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Texas Oncology - San Antonio (San Antonio, TX); Texas Oncology - San Antonio (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  2. Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

    NCT05005403

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NEXT Oncology /ID# 243007 (San Antonio, TX); South Texas Accelerated Research Therapeutics (START) /ID# 276268 (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  3. A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

    NCT05208762

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NEXT Virginia, LLC (San Antonio, TX); South Texas Accelerated Research Therapeutics, LLC (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  4. Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

    NCT06128551

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NEXT Oncology San Antonio (San Antonio, TX); START Texas (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  5. A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

    NCT06244771

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: South Texas Accelerated Research Therapeutics, LLC (San Antonio, TX); UT Health San Antonio (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. CT-95 in Advanced Cancers Associated With Mesothelin Expression

    NCT06756035

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Context Investigational Site (San Antonio, TX); Context Investigational Site (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

    NCT06835569

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (San Antonio, TX); Research Site #2 (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

    NCT07168993

    • Interventional
    • Ages 50 to 80 years
    • Sex: All

    Nearest sites: Audie Murphy VA Medical Center (San Antonio, TX); Brooke Army Medical Center (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  9. A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

    NCT07300150

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: New Experimental Therapeutics of San Antonio LLC (San Antonio, TX); START - South Texas Accelerated Research Therapeutics, LLC (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  10. Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

    NCT07349537

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NEXT (San Antonio, TX); START - San Antonio (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    NCT07503808

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NEXT Texas LLC - San Antonio (San Antonio, TX); START San Antonio, LLC (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

    NCT07540572

    • Phase 1
    • Ages 18 to 99 years
    • Sex: All

    Nearest sites: NEXT Texas LLC - San Antonio (San Antonio, TX); Start San Antonio, LLC (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. Collection of Sputum and Labeling for Lung Cancer

    NCT03457415

    • Observational
    • Ages 21 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: South Texas Veterans Health Care System (STVHCS)/Audie L. Murphy Memorial Veterans Hospital (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

    NCT03460977

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: NEXT Oncology (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

    NCT03655015

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: UT Health San Antonio, M.D. Anderson Cancer Center (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest site: New Experimental Therapeutics of San Antonio - NEXT Oncology (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Study of PF-07248144 in Advanced or Metastatic Solid Tumors

    NCT04606446

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: NEXT Oncology (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

    NCT04665206

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: NEXT Oncology (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

    NCT05059444

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: The University of Texas Health Science Center at San Antonio (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

    NCT05245500

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: South Texas Accelerated Research Therapeutics (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

    NCT05267626

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: START South Texas Accelerated Research Therapeutics (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Audie L Murphy VA Hospital (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

    NCT05379985

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Next Oncology (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors

    NCT05417321

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Next Oncology (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

    NCT05592626

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: UT Health Mays Cancer Center (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

    NCT05652686

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Mays Cancer Center / University of Texas, San Antonio (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    NCT05786924

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: START San Antonio (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

    NCT05985655

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: START San Antonio (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

    NCT06040541

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: START (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

    NCT06090266

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: NEXT Oncology (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

    NCT06131840

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: South Texas Accelerated Research Therapeutics, LLC (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

    NCT06216301

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Jason Bates at University of Texas Health Science Center (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

    NCT06236438

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Texas Oncology - San Antonio Medical Center - Research Drive /ID# 264311 (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

    NCT06239194

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: NEXT Oncology (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

    NCT06293898

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: START - San Antonio (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

    NCT06385925

    • Phase 1/2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: NEXT Oncology (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

    NCT06451497

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: NEXT Oncology (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    NCT06465069

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: South Texas Accelerated Research Therapeutics (START) (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

    NCT06582017

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: START San Antonio (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

    NCT06586515

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: South Texas Accelerated Research Therapeutics (START) (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

    NCT06625775

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Texas San Antonio (UTSA) (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

    NCT06657222

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: NEXT Oncology - San Antonio (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    NCT06667076

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Texas Oncology San Antonio Northeast (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. A Study of MGC028 in Participants With Advanced Solid Tumors

    NCT06723236

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: South Texas Accelerated Research Therapeutics (START) San Antonio (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. A Phase 1 Study of LNCB74 in Advanced Solid Tumors

    NCT06774963

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: UT Health San Antonio - MD Anderson Cancer Center (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

    NCT06784193

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: START - San Antonio (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

    NCT06799065

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: NEXT Oncology (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

    NCT06875310

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Texas Oncology - San Antonio (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

    NCT06890598

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: USO - Texas Oncology - San Antonio (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. IDOV-Immune for Advanced Solid Tumors

    NCT06910657

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: South Texas Accelerated Research Therapeutics (San Antonio, TX)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lung Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.